Roche develops new test kits for the omicron variant

FILE PHOTO: Poster at a diagnostic site for Swiss pharmaceutical giant Roche, in Burgess Hill, UK, on ​​October 7, 2020. REUTERS / Peter Nicholls / File Photo

ZURICH, Dec 3 (Reuters) – Roche’s recently acquired subsidiary TIB Molbiol has developed three new test kits to detect the mutations present in omicron, the new variant of COVID-19, Roche reported on Friday.

“The TIB Molbiol teams have worked tirelessly since the new variant emerged, and today we are able to offer a test that can specifically identify the new B.1.1.529 omicron variant of SARS-CoV-2 to help better understand its spread and behavior, “said Thomas Schinecker, head of Roche Diagnostics, in a statement.

Roche acquired Berlin-based TIB Molbiol on December 1 to expand its portfolio of PCR tests in new infectious diseases.

(Reporting by Brenna Hughes Neghaiwi; Editing by Paul Carrel; translated by Tomás Cobos)

Leave a Reply

Your email address will not be published. Required fields are marked *